T
25.30
-0.49 (-1.90%)
| Previous Close | 25.79 |
| Open | 25.96 |
| Volume | 1,402,486 |
| Avg. Volume (3M) | 1,853,608 |
| Market Cap | 1,715,399,680 |
| Price / Earnings (Forward) | 1.11 |
| Price / Sales | 1.26 |
| Price / Book | 9.67 |
| 52 Weeks Range | |
| Earnings Date | 29 Apr 2026 |
| Profit Margin | -18.71% |
| Operating Margin (TTM) | -14.71% |
| Diluted EPS (TTM) | -2.79 |
| Quarterly Revenue Growth (YOY) | 22.30% |
| Total Debt/Equity (MRQ) | 320.75% |
| Current Ratio (MRQ) | 2.30 |
| Operating Cash Flow (TTM) | 13.94 M |
| Levered Free Cash Flow (TTM) | 67.48 M |
| Return on Assets (TTM) | -6.17% |
| Return on Equity (TTM) | -92.31% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Bearish | |
| Stock | Tandem Diabetes Care, Inc. | Bullish | Bearish |
AIStockmoo Score
-1.0
| Analyst Consensus | -1.5 |
| Insider Activity | -3.0 |
| Price Volatility | -4.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 4.0 |
| Average | -1.00 |
|
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Core |
| % Held by Insiders | 0.95% |
| % Held by Institutions | 110.87% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Sessa Capital Im, L.P. | 31 Dec 2025 | 5,000,000 |
| Arrowmark Colorado Holdings Llc | 31 Dec 2025 | 2,889,691 |
| Gw&K Investment Management, Llc | 31 Dec 2025 | 2,675,157 |
| Paradice Investment Management Llc | 31 Dec 2025 | 2,077,745 |
| Freestone Grove Partners Lp | 31 Dec 2025 | 1,442,836 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 50.00 (Lake Street, 97.63%) | Buy |
| Median | 25.00 (-1.19%) | |
| Low | 21.00 (Piper Sandler, -17.00%) | Hold |
| Average | 27.82 (9.96%) | |
| Total | 3 Buy, 8 Hold | |
| Avg. Price @ Call | 24.28 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Lake Street | 23 Feb 2026 | 50.00 (97.63%) | Buy | 28.26 |
| Truist Securities | 23 Feb 2026 | 27.00 (6.72%) | Hold | 28.26 |
| 18 Dec 2025 | 24.00 (-5.14%) | Hold | 21.80 | |
| B of A Securities | 20 Feb 2026 | 30.00 (18.58%) | Hold | 24.57 |
| Mizuho | 20 Feb 2026 | 22.00 (-13.04%) | Hold | 24.57 |
| 17 Dec 2025 | 21.00 (-17.00%) | Hold | 22.42 | |
| Piper Sandler | 20 Feb 2026 | 21.00 (-17.00%) | Hold | 24.57 |
| Stifel | 20 Feb 2026 | 22.00 (-13.04%) | Hold | 24.57 |
| 04 Feb 2026 | 20.00 (-20.95%) | Hold | 18.99 | |
| UBS | 20 Feb 2026 | 22.00 (-13.04%) | Hold | 24.57 |
| Bernstein | 09 Jan 2026 | 25.00 (-1.19%) | Hold | 21.70 |
| Canaccord Genuity | 17 Dec 2025 | 35.00 (38.34%) | Buy | 22.42 |
| Baird | 16 Dec 2025 | 30.00 (18.58%) | Buy | 22.60 |
| Citigroup | 11 Dec 2025 | 22.00 (-13.04%) | Hold | 20.97 |
| Show more | ||||
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| CARPENTER RICK | - | 18.84 | -1,312 | -24,718 |
| GASSER ELIZABETH ANNE | - | 18.84 | -1,534 | -28,901 |
| HANSEN SHANNON MARIE | - | 18.84 | -1,263 | -23,795 |
| MORRISON SUSAN | - | 18.84 | -882 | -16,617 |
| NOVARA MARK DAVID | - | 18.84 | -62 | -1,168 |
| SHERIDAN JOHN F | - | 18.84 | -4,363 | -82,199 |
| VOSSELLER LEIGH | - | 18.84 | -1,235 | -23,267 |
| Aggregate Net Quantity | -10,651 | |||
| Aggregate Net Value ($) | -200,665 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 18.84 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| HANSEN SHANNON MARIE | Officer | 17 Feb 2026 | Disposed (-) | 1,263 | 18.84 | 23,795 |
| HANSEN SHANNON MARIE | Officer | 17 Feb 2026 | Option execute | 3,065 | - | - |
| VOSSELLER LEIGH | Officer | 17 Feb 2026 | Disposed (-) | 1,235 | 18.84 | 23,267 |
| VOSSELLER LEIGH | Officer | 17 Feb 2026 | Option execute | 2,998 | - | - |
| SHERIDAN JOHN F | Officer | 17 Feb 2026 | Disposed (-) | 4,363 | 18.84 | 82,199 |
| SHERIDAN JOHN F | Officer | 17 Feb 2026 | Option execute | 11,454 | - | - |
| NOVARA MARK DAVID | Officer | 17 Feb 2026 | Disposed (-) | 62 | 18.84 | 1,168 |
| NOVARA MARK DAVID | Officer | 17 Feb 2026 | Option execute | 77 | - | - |
| MORRISON SUSAN | Officer | 17 Feb 2026 | Disposed (-) | 882 | 18.84 | 16,617 |
| MORRISON SUSAN | Officer | 17 Feb 2026 | Option execute | 2,600 | - | - |
| GASSER ELIZABETH ANNE | Officer | 17 Feb 2026 | Disposed (-) | 1,534 | 18.84 | 28,901 |
| GASSER ELIZABETH ANNE | Officer | 17 Feb 2026 | Option execute | 2,600 | - | - |
| CARPENTER RICK | Officer | 17 Feb 2026 | Disposed (-) | 1,312 | 18.84 | 24,718 |
| CARPENTER RICK | Officer | 17 Feb 2026 | Option execute | 2,334 | - | - |
| Show more | ||||||
| Date | Type | Details |
|---|---|---|
| 08 Jan 2026 | Announcement | Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026 |
| 18 Dec 2025 | Announcement | Tandem t:slim Mobile App Now Available in Canada |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |